Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clostridium”

778 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 778 results

Large-scale testing (Phase 3)Study completedNCT01086423
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine

Who this might be right for
TetanusPoliomyelitisAcellular Pertussis+2 more
GlaxoSmithKline 985
Post-approval studies (Phase 4)Study completedNCT01031303
What this trial is testing

Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of Age

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Sanofi 123
Large-scale testing (Phase 3)Study completedNCT00148941
What this trial is testing

Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines

Who this might be right for
TetanusAcellular PertussisDiphtheria
GlaxoSmithKline 4,209
Large-scale testing (Phase 3)Looking for participantsNCT07221370
What this trial is testing

Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients

Who this might be right for
Clostridium Difficile InfectionVancomycin Resistant Enterococci Infection
Riverside University Health System Medical Center 176
Post-approval studies (Phase 4)Study completedNCT02951702
What this trial is testing

Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk Antibiotics

Who this might be right for
Clostridium Difficile InfectionProphylaxisVancomycin
St. Luke's Hospital, Chesterfield, Missouri 51
Early research (Phase 1)Study completedNCT02889848
What this trial is testing

Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) to Treat Uterine Leiomyoma (Fibroids)

Who this might be right for
Fibroids, UterineLeiomyoma
Advance Biofactures Corporation 15
Large-scale testing (Phase 3)Study completedNCT01444781
What this trial is testing

Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants

Who this might be right for
DiphtheriaTetanusWhooping Cough+2 more
Sanofi Pasteur, a Sanofi Company 1,106
Large-scale testing (Phase 3)Study completedNCT01346293
What this trial is testing

Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age

Who this might be right for
TetanusDiphtheriaPertussis+2 more
Sanofi Pasteur, a Sanofi Company 3,372
Not applicableUnknownNCT05430269
What this trial is testing

Faecal Bacteriotherapy for Postantibiotic Diarrhoea in Critically Ill Patients

Who this might be right for
Diarrhea Caused by DrugClostridium Difficile Infections
Charles University, Czech Republic 36
Testing effectiveness (Phase 2)Study completedNCT04580303
What this trial is testing

CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques

Who this might be right for
Edematous Fibrosclerotic PanniculopathyCelluliteLaxity; Skin
Endo Pharmaceuticals 35
Not applicableStudy completedNCT01957761
What this trial is testing

Molecular Epidemiology of Clostridium Difficile Infections in Children

Who this might be right for
Clostridium Difficile Infections
Ann & Robert H Lurie Children's Hospital of Chicago 132
Large-scale testing (Phase 3)Study completedNCT00777803
What this trial is testing

NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines

Who this might be right for
Glabellar Frown Lines
Merz Pharmaceuticals GmbH 381
Post-approval studies (Phase 4)Enrolling By InvitationNCT02051062
What this trial is testing

BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric Patients

Who this might be right for
Botulism
Emergent BioSolutions 10
Not applicableStudy completedNCT02086916
What this trial is testing

Novel Biomarkers to Predict Outcome in Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile Infection
Barts & The London NHS Trust 122
Large-scale testing (Phase 3)Ended earlyNCT01226992
What this trial is testing

Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral Vancomycin

Who this might be right for
Recurrent Clostridium Difficile InfectionLaboratory Confirmed Clostridium Difficile Infection
University Health Network, Toronto 81
Large-scale testing (Phase 3)Study completedNCT06817187
What this trial is testing

Clinical Study on the Combined Administration of 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus, Pertussis Vaccine

Who this might be right for
Streptococcus Pneumoniae Infections
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 1,110
Large-scale testing (Phase 3)UnknownNCT02774382
What this trial is testing

Rectal Bacteriotherapy, Fecal Microbiota Transplantation or Oral Vancomycin Treatment of Recurrent Clostridium Difficile Infections

Who this might be right for
Clostridium Difficile
Hvidovre University Hospital 450
Post-approval studies (Phase 4)Ended earlyNCT03937999
What this trial is testing

Bezlotoxumab as Secondary Prophylaxis for C. Difficile in High-risk Hospitalized Patients Exposed to Antibiotics.

Who this might be right for
Clostridium Difficile
Montefiore Medical Center 1
Not applicableEnded earlyNCT01533844
What this trial is testing

To Determine the Feasibility of a Fidaxomicin Study in Neonates and to Assess C. Difficile (Clostridium Difficile) Involvement in the Pathogenesis

Who this might be right for
Clostridium Difficile
Astellas Pharma Europe B.V. 1
Not applicableLooking for participantsNCT05709184
What this trial is testing

Lyophilized Fecal Microbiome Transfer vs. Vancomycin Monotherapy for Primary Clostridioides Difficile Infection

Who this might be right for
Clostridioides Difficile Infection
Rambam Health Care Campus 196
Load More Results